Bioengineered Peptides Based on α1-PDX Structure as Inhibitors of Furin: Design, Synthesis and Comparative Efficacy Bioengineered peptides as inhibitors of furin
Iranian Journal of Pharmaceutical Sciences,
Vol. 2 No. 1 (2006),
15 January 2006
,
Page 11-22
https://doi.org/10.22037/ijps.v2.39576
Abstract
Furin is a Ca2+ -dependent serine protease which cleaves proprotein substrates at the Arg-Xaa-(Lys/Arg)-Arg site to generate biologically active proteins. Furin’s
critical role in many cellular events associated with health disorders such as HIV, SARS, anthrax, and influenza as well as cancer has made inhibitors of this enzyme as therapeutic targets. To this date, the most potent inhibitor of furin is the bioengineered serpin (serine protease inhibitors) protein namely α1-PDX. It was already demonstrated that the reactive site loop (RSL) of all serpins are prime interactive domains responsible for their protease inhibitory function. Therefore, the objective of the present study was to develop small peptides with the RSL structure of serpin α1-PDX, as inhibitors of furin activity. Fifteen peptides were designed from reactive site loop structure of α1-PDX (sequences 367-394) with different mutations in this site, and were synthesized using a solid-phase peptide synthesizer, and characterized by MALDI-tof mass spectrometry and amino acid analysis. The inhibitory effects of the designed peptides against furin activity were evaluated by spectroflourometry using QVEGF-C [Abz-QVHSIIRRßSLP-Y(NO2)-A-CONH2, Abz = 2-amino benzoic acid and Y(NO2) = 3-nitro tyrosine] as substrate. The results showed that all of the designed peptides inhibit furin activity with different efficacies in a time and concentration dependent pattern. Peptides containing His or straight alkyl side chain amino acids in positions P2, P3, P6 and P8 have higher efficacy for blocking furin activity in comparison with peptides containing Arg or Lys in that position. The study further revealed that the peptides inactivate furin in a slow tight binding pattern. Our study provides an alternate strategy for development of efficient peptide-based inhibitors of proprotein convertases such as furin.
- α1-PDX; Furin
- Proprotein convertase
- Protease inhibitor
- Serpin
How to Cite
References
[2] Seidah NG, Chrétien M. Proprotein and prohormone convertases: A family of subtilases generating diverse bioactive polypeptides. Brain Research 1999; 848: 45-62.
[3] Denault JB, Leduc R. Furin/PACE/SPC 1: A convertase involved in exocytic and endocytic processing of precursor proteins. FEBS Lett 1996; 379: 113-6.
[4] Rockwell NC, Krysan DJ, Komiyama T, Fuller RS. Precursor processing by Kex2/furin proteases. Chem Rev 2002; 102: 4525-48.
[5] Steiner DF. The proprotein convertases. Curr Opin Chem Biol 1998; 2: 31-9. Bioengineered
[6] Basak A, Zhong M, Munzer JS, Chrétien M, Seidah NG. Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: A comparative analysis using fluorogenic peptides. Biochem J 2001; 353: 537-45.
[7] Chrétien M, Mbikay M, Gaspar L, Seidah NG. Proprotein convertases and the pathophysiology of human diseases: Prospective considerations. Proc Assoc Am Physicians 1995; 107: 47-66.
[8] Khatib AM, Siegfried G, Prat A, Luis J, Chretien M, Metrakos P, Seidah NG. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: Importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J Biol Chem 2001; 276: 30686-93.
[9] Villemure M, Fournier A, Gauthier D, Rabah N, Wilkes BC, Lazure C. Barley serine proteinase inhibitor-2 derived cyclic peptides as potent and selective inhibitors of convertases PC1/3 and furin. Biochemistry 2003; 42: 9659-68.
[10] Zhong M, Munzer JS, Basak A, Benjannet S, Mowla SJ, Decroly E, Chretien M, Seidah NG. The prosegments of furin and PC7 as potent inhibitors of proprotein convertases: In vitro and ex vivo assessment of their efficacy and selectivity. J Biol Chem 1999; 274: 33913-20.
[11] Kang UB, Baek JH, Kim SHRJ, Yu MH, Lee C. Kinetic mechanism of protease inhibition by α1-antitrypsin. Biochem Biophys Res Comm 2004; 323: 409–15.
[12] Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. Human furin is a calciumdependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 1992; 267: 16396-402.
[13] Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chrétien M, Seidah NG, Khatib AB. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clinical Invest 2003; 111: 1723-32.
[14] Amino acid analysis, Perkin Elmer Applied Biosystems; 2004 [on line], Available from http://www.biotech.iastate.edu/facilities/protein/aaa.html.
[15] Brown RS, Lennon JJ. Mass resolution improvement by incorporation of pulsed ion extraction in a matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometer. Anal Chem 1995; 67: 1998-2003.
[16] Khatib AM, Siegfried G, Chretien M, Metrakos P, Seidah NG. Proprotein convertases in tumor progression and malignancy: Novel targets in cancer therapy. Am J Pathol 2002; 160: 1921-35.
[17] Jean F, Basak A, Dugas H, Lazure C. Design of octapeptide loop structures by modeling the active site region of barley serine proteinase inhibitor. In: Hodges RS, Smith JA, (editors). Peptides, chemistry, structure and biology ESCOM. Leiden, Netherlands, Peptides, Proceedings of 13th American Peptide Symposium 1994; pp. 613-5.
[18] Decroly E, Vandenbranden M, Ruysschaert JM, Jacob GS, Howard SC, Marshall G, Kompelli A, Basak A, Jean F, Lazure C, Benjannet S, Chretien M, Day R, Seidah NG. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J Biol Chem 1994; 269: 12240-7.
[19] Bergeron E, Vincent MJ, Wickham L, Hamelin J, Basak A, Nichol ST, Chretien M, Seidah NG. Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus. Biochem Biophys Res Comm 2005; 326: 554-63.
[20] Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci 1998; 95: 5762-7.
[21] Jean FK, Stella L, Thomas G, Liu Y, Xiang AJ, Reason A, Thomas G. α1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: Application as an antipathogenic agent. Proc Natl Acad Sci 1998; 95: 7293-8.
[22] Gettins PGW. Serpin structure, mechanism and function. Chem Rev 2002; 102: 4751-803.
[23] Irving JA, Pike RM, Lesk AM, Whisstock JC. Phylogeny of the serpin superfamily: Implications of patterns of amino acid conservation for structure and function. Genome Res. 2000; 10: 1845-64.
[24] Klimpel KR, Molloy SS, Thomas G, Leppla SH. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence
specificity and catalytic properties of furin. Proc Natl Acad Sci 1992; 89: 10277-81.
[25] Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. Human furin is a calciumdependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 1992; 267: 16396-402.
[26] Molloy SS, Thomas L, van Slyke JK, Stenberg PE, Thomas G. Intracellular trafficking and activation of the furin proprotein convertase: Localization to the TGN and recycling from thecell surface. EMBO J 1994; 13: 18-33.
[27] Hatsuzawa K, Nagahama M, Takahashi S, Takada K, Murakami K, Nakayama K. Purification and characterization of furin, a Kex2-like processing endoprotease, produced in chinese hamster ovary cells. J Biol Chem 1992; 267: 16094-9.
[28] Takahashi S, Hatsuzawa K, Watanabe T, Murakami K, Nakayama K. A Kex2-related endopeptidase activity present in rat liver specifically processes the insulin proreceptor. J Biochem (Tokyo) 1994; 116: 47-52.
- Abstract Viewed: 90 times
- IJPS_Volume 2_Issue 1_Pages 11-22 Downloaded: 11 times